Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionWbh Advisory Inc
Latest Disclosed Ownership1,722 shares
Latest Disclosed Value $ 608,348
Wbh Advisory Inc ownership in AMGN / Amgen Inc.

On April 27, 2026 - Wbh Advisory Inc filed a 13F-HR form disclosing ownership of 1,722 shares of Amgen Inc. (MX:AMGN) valued at $608,348 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 1,722 shares of Amgen Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F AMGEN COM 031162100 1,722 0 0.00 608 7.99 0.0456
2026-01-26 2025-12-31 13F AMGEN COM 031162100 1,722 0 0.00 564 16.08 0.0417
2025-10-30 2025-09-30 13F AMGEN COM 031162100 1,722 -5 -0.29 486 0.62 0.0371
2025-07-30 2025-06-30 13F AMGEN COM 031162100 1,727 -52 -2.92 482 -13.00 0.0411
2025-05-12 2025-03-31 13F AMGEN COM 031162100 1,779 -27 -1.50 554 17.87 0.0517
2025-01-31 2024-12-31 13F AMGEN COM 031162100 1,806 -37 -2.01 471 -20.74 0.0437
2024-10-15 2024-09-30 13F AMGEN COM 031162100 1,843 199 12.10 594 15.59 0.0562
2024-07-11 2024-06-30 13F AMGEN COM 031162100 1,644 1 0.06 514 9.85 0.0520
2024-04-16 2024-03-31 13F AMGEN COM 031162100 1,643 -33 -1.97 467 -3.11 0.0481
2024-01-09 2023-12-31 13F AMGEN COM 031162100 1,676 -15 -0.89 483 6.17 0.0537
2023-10-10 2023-09-30 13F AMGEN COM 031162100 1,691 14 0.83 455 22.04 0.0558
2023-07-12 2023-06-30 13F AMGEN COM 031162100 1,677 1 0.06 372 -8.15 0.0441
2023-04-20 2023-03-31 13F AMGEN COM 031162100 1,676 22 1.33 405 8.58 0.0506
2022-10-18 2022-09-30 13F AMGEN COM 031162100 1,654 1 0.06 373 -9.02 0.0538
2022-07-12 2022-06-30 13F AMGEN COM 031162100 1,653 0 0.00 410 4.06 0.0547
2022-04-29 2022-03-31 13F AMGEN COM 031162100 1,653 -114 -6.45 394 -0.76 0.0484
2022-01-28 2021-12-31 13F AMGEN COM 031162100 1,767 1 0.06 397 5.87 0.0453
2021-10-25 2021-09-30 13F AMGEN COM 031162100 1,766 4 0.23 375 -13.19 0.0505
2021-07-27 2021-06-30 13F AMGEN COM 031162100 1,762 2 0.11 432 -1.37 0.0633
2021-04-19 2021-03-31 13F AMGEN COM 031162100 1,760 -14 -0.79 438 -2.23 0.0709
2021-01-21 2020-12-31 13F AMGEN COM 031162100 1,774 22 1.26 448 0.67 0.0771
2020-10-27 2020-09-30 13F AMGEN COM 031162100 1,752 33 1.92 445 9.88 0.0898
2020-08-05 2020-06-30 13F Amgen COM 031162100 1,719 2 0.12 405 16.38 0.0980
2020-05-07 2020-03-31 13F Amgen COM 031162100 1,717 2 0.12 348 -15.74 0.0816
2020-01-27 2019-12-31 13F Amgen COM 031162100 1,715 -24 -1.38 413 22.92 0.0844
2019-10-25 2019-09-30 13F Amgen COM 031162100 1,739 2 0.12 336 5.00 0.0755
2019-08-02 2019-06-30 13F Amgen COM 031162100 1,737 1 0.06 320 -2.74 0.0742
2019-04-22 2019-03-31 13F Amgen COM 031162100 1,736 2 0.12 329 -2.37 0.0783
2019-01-29 2018-12-31 13F Amgen COM 031162100 1,734 1 0.06 337 -6.13 0.0818
2018-10-29 2018-09-30 13F Amgen COM 031162100 1,733 2 0.12 359 12.54 0.0870
2018-07-31 2018-06-30 13F Amgen COM 031162100 1,731 1 0.06 319 8.50 0.0827
2018-04-30 2018-03-31 13F Amgen COM 031162100 1,730 1 0.06 294 -2.00 0.0799
2018-01-31 2017-12-31 13F Amgen COM 031162100 1,729 2 0.12 300 -6.83 0.0800
2017-11-29 2017-09-30 13F Amgen COM 031162100 1,727 1 0.06 322 8.42 0.0899
2017-07-21 2017-06-30 13F Amgen COM 031162100 1,726 2 0.12 297 5.32 0.0833
2017-04-21 2017-03-31 13F Amgen COM 031162100 1,724 1 0.06 282 11.90 0.0845
2017-01-20 2016-12-31 13F Amgen COM 031162100 1,723 1 0.06 252 -12.20 0.0840
2016-10-24 2016-09-30 13F Amgen COM 031162100 1,722 1 0.06 287 9.96 0.0982
2016-07-25 2016-06-30 13F Amgen COM 031162100 1,721 1 0.06 261 1.56 0.1016
2016-04-15 2016-03-31 13F Amgen COM 031162100 1,720 2 0.12 257 -7.55 0.0860
2016-01-19 2015-12-31 13F Amgen COM 031162100 1,718 1 0.06 278 17.30 0.0972
2015-10-15 2015-09-30 13F Amgen COM 031162100 1,717 1 0.06 237 -9.89 0.0985
2015-07-20 2015-06-30 13F Amgen COM 031162100 1,716 1 0.06 263 -4.01 0.1034
2015-04-22 2015-03-31 13F Amgen COM 031162100 1,715 29 1.72 274 2.24 0.0769
2015-01-23 2014-12-31 13F Amgen COM 031162100 1,686 0 0.00 268 13.56 0.1011
2014-10-17 2014-09-30 13F Amgen COM 031162100 1,686 -49 -2.82 236 15.12 0.0829
2014-07-21 2014-06-30 13F Amgen COM 031162100 1,735 1 0.06 205 -3.76 0.0775
2014-04-29 2014-03-31 13F Amgen COM 031162100 1,734 1,734 213 0.0847
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.